324
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Role of glutathione-s-transferase (gst) polymorphisms in patients with advanced hodgkin lymphoma: results from the hd2000 GISL trial

, , , , , , , , , , , , , & show all
Pages 406-410 | Received 14 May 2011, Accepted 09 Sep 2011, Published online: 14 Sep 2011

References

  • Diehl V, Franklin J, Pfreundschuh M, . German Hodgkin's Lymphoma Study Group. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 2003;348:2386–2395.
  • Engert A, Diehl V, Franklin J, . Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study. J Clin Oncol 2009;27: 4548–554.
  • Josting A, Wiedenmann S, Franklin J, . German Hodgkin's Lymphoma Study Group. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 2003;21:3440–3446.
  • Sieniawski M, Reineke T, Nogova L, . Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG). Blood 2008; 111:71–76.
  • Federico M, Luminari S, Iannitto E, . HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial. ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial. J Clin Oncol 2009; 27:805–811.
  • Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. N Engl J Med 1998;339:1506–1514.
  • Abraham J, Earl HM, Pharoah PD, . Pharmacogenetics of cancer chemotherapy. Biochim Biophys Acta 2006;1766:168–183.
  • McIlwain CC, Townsend DM, Tew KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 2006;25: 1639–1648.
  • Strange RC, Jones PW, Fryer AA. Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett 2000;112–113:357–363.
  • Seidegård J, Vorachek WR, Pero RW, . Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A 1988; 85:7293–7297.
  • Pemble S, Schroeder KR, Spencer SR, . Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300:271–276.
  • Stanulla M, Schrappe M, Brechlin AM, . Polymorphisms within glutathione Stransferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study. Blood 2000;95:1222–1228.
  • Voso MT, D'Alo’ F, Putzulu R, . Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood 2002;100:2703–2707.
  • D'Alò F, Voso MT, Guidi F, . Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia. Haematologica 2004;89:664–670.
  • Hohaus S, Massini G, D'Alo’ F, . Association between glutathione S-transferase genotypes and Hodgkin's lymphoma risk and prognosis. Clin Cancer Res 2003;9:3435–3440.
  • Hohaus S, Mansueto G, Massini G, . Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. Leuk Lymphoma 2007;48:564–9.
  • Voso MT, Hohaus S, Guidi F, . Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. Leukemia 2008;22:1685–1691.
  • Watson MA, Stewart RK, Smith GB, . Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998; 19:275–280.
  • Hohaus S, Di Ruscio A, Di Febo A, . Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma. Clin Cancer Res 2005;11:2175–2179.
  • Ribrag V, Koscielny S, Casasnovas O, . Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis. Blood 2009;113:3307–3313.
  • Harries LW, Stubbins MJ, Forman D, . Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997;18:641–644.
  • Oken MM, Creech RH, Tormey DC, . Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649–655.
  • Hasenclever D. The disappearance of prognostic factors in Hodgkin's disease. Ann Oncol 2002;13 Suppl 1:75–78.
  • Kearns PR, Pieters R, Rottier MM, . Raised blast glutathione levels are associated with an increased risk of relapse in childhood acute lymphocytic leukemia. Blood 2001;97:393–398.
  • Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 2003;22:7369–7375.
  • Zhong S, Huang M, Yang X, . Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupuserythematosus. Br J Clin Pharmacol 2006;62:457–472.
  • Yokomizo A, Yamamoto K, Kinukawa N, . Association analysis of glutathione-Stransferase P1 (GSTP1) polymorphism with urothelial cancer susceptibility and myelosuppression after M-VAC chemotherapy. Int J Urol 2007;14:500–504.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.